Literature DB >> 20026787

Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.

Frans Van de Werf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20026787     DOI： 10.1161/CIR.0b013e3181cd3d17

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Authors:  Charles Brown; Brijen Joshi; Nauder Faraday; Ashish Shah; David Yuh; Jeffrey J Rade; Charles W Hogue
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

2.  The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody.

Authors:  Kanako Sugiyama; Mitsuhiro Iyori; Asuka Sawaguchi; Satoko Akashi; Jeremy R H Tame; Sam-Yong Park; Shigeto Yoshida
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

3.  The bleeding risk score as a mortality predictor in patients with acute coronary syndrome.

Authors:  José Carlos Nicolau; Humberto Graner Moreira; Luciano Moreira Baracioli; Carlos Vicente Serrano; Felipe Galego Lima; Marcelo Franken; Roberto Rocha Giraldez; Fernando Ganem; Roberto Kalil Filho; José Antônio Franchini Ramires; Roxana Mehran
Journal:  Arq Bras Cardiol       Date:  2013-11-12       Impact factor: 2.000

4.  Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation.

Authors:  Jeremy A Nestele; Anne-Katrin Rohlfing; Valerie Dicenta; Alexander Bild; Daniela Eißler; Frederic Emschermann; Marcel Kremser; Konstantin Krutzke; Tilman E Schäffer; Oliver Borst; Moran Levi; Netanel Korin; Meinrad Paul Gawaz
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.